Efficacy and Safety of Romiplostim in Patients with Low or Intermediate-Risk Myelodysplastic Syndrome (MDS) Receiving Decitabine Greenberg, P. L., Garcia-Manero, G., Moore, M. R., Damon, L. E., Roboz, G. J., Wei, H., Kantarjian, H., Franklin, J. L. AMER SOC HEMATOLOGY. 2009: 703

View details for Web of Science ID 000272725802137